Home Forschung AG Molekulare Bild ...
Über uns
Minimalinvasive Tumortherapie
Aktuelle Stellenausschreibungen
Publications 2002 - 2017 19.02.2018 


2002 - 2016

38. LA-ICP-MS Allows Quantitative Microscopy of Europium-Doped Iron Oxide Nanoparticles and is a Possible Alternative to Ambiguous Prussian Blue Iron Staining
Scharlach, C., Müller, L., Wagner, S., Kobayashi, Y., Kratz, H., Ebert, M., Jakubowski, N. & Schellenberger, E.
Journal of biomedical nanotechnology, 2016 12(5), pp. 1001-10

37. Labeling of mesenchymal stem cells for MRI with single-cell sensitivity
Ariza de Schellenberger, A., Kratz, H., Farr, T., Loewa, N., Hauptmann, R., Wagner, S., Taupitz, M., Schnorr, J. & Schellenberger, E.
International journal of nanomedicine, 2016, p. 1517.

36. Determination of blood circulation times of superparamagnetic iron oxide nanoparticles by T2* relaxometry using ultrashort echo time (UTE) MRI.
Scharlach C, Warmuth C, Schellenberger E.
Magn Reson Imaging. 2015 Nov;33(9):1173-7. doi: 10.1016/j.mri.2015.06.017. Epub 2015 Jun 26.

35. Synthesis of acid-stabilized iron oxide nanoparticles and comparison for targeting atherosclerotic plaques: evaluation by MRI, quantitative MPS, and TEM alternative to ambiguous Prussian blue iron staining.
Scharlach C, Kratz H, Wiekhorst F, Warmuth C, Schnorr J, Genter G, Ebert M, Mueller S, Schellenberger E.
Nanomedicine. 2015 Jul;11(5):1085-95. doi: 10.1016/j.nano.2015.01.002. Epub 2015 Feb 4.

34. Direct coupling of annexin A5 to VSOP yields small, protein-covered nanoprobes for MR imaging of apoptosis.
Figge L, Appler F, Chen HH, Sosnovik DE, Schnorr J, Seitz O, Taupitz M, Hamm B, Schellenberger E.
Contrast Media Mol Imaging. 2014 Jul-Aug;9(4):291-9. doi: 10.1002/cmmi.1575.

33. XTEN-annexin A5: XTEN allows complete expression of long-circulating protein-based imaging probes as recombinant alternative to PEGylation.
Haeckel A, Appler F, Figge L, Kratz H, Lukas M, Michel R, Schnorr J, Zille M, Hamm B, Schellenberger E.
J Nucl Med. 2014 Mar;55(3):508-14. doi: 10.2967/jnumed.113.128108. Epub 2014 Feb 18.

32. Monitoring stroke pregression: in vivo imaging of cortical perfusion, blood-brain barrier permeability and celluar damage in the rat photothrombosis model.
Schoknecht K, Prager O, Vazana U, Kamintsky L, Harhausen D, Zille M, Figge L, Chassidim Y, Schellenberger E, Kovács R, Heinemann U, Friedman A.
J Cereb Blood Flow Metab. 2014 Nov;34(11):1791-801. doi: 10.1038/jcbfm.2014.147. Epub 2014 Aug 27.

31. Certain types of iron oxide nanoparticles are not suited to passively target inflammatory cells that infiltrate the brain in response to stroke.
J Cereb Blood Flow Metab. 2013 May;33(5):e1-9. doi: 10.1038/jcbfm.2013.22. Epub 2013 Feb 27.

30. Imaging of magnetic microfield disortions allows sensitive single-cell detection.
Lindquist RL, Papazoglou S, Scharlach C, Waiczies H, Schnorr J, Taupitz M, Hamm B, Schellenberger E.
Mol Imaging. 2013 Mar-Apr;12(2):83-9.

29. Kratz H, Haeckel A, Michel R, Schönzart L, Hanisch U, Hamm B, Schellenberger E.
Straightforward thiol-mediated protein labelling with DTPA: Synthesis of a highly active 111In-annexin A5-DTPA tracer.

EJNMMI Res. 2012 Apr 27;2(1):17

28. Schnorr J, Taupitz M, Schellenberger EA, Warmuth C, Fahlenkamp UL, Wagner S, Kaufels N, Wagner M.
Cardiac magnetic resonance angiography using blood-pool contrast agents: comparison of citrate-coated very small superparamagnetic iron oxide particles with gadofosveset trisodium in pigs.
Rofo. 2012 Feb;184(2):105-12

27. Wuerfel E, Smyth M, Millward JM, Schellenberger E, Glumm J, Prozorovski T, Aktas O, Schulze-Topphoff U, Schnorr J, Wagner S, Taupitz M, Infante-Duarte C, Wuerfel J
Electrostatically Stabilized Magnetic Nanoparticles - An Optimized Protocol to Label Murine T Cells for in vivo MRI.
Front Neurol. 2011;2:72. Epub 2011 Dec 16

26. Wagner M, Wagner S, Schnorr J, Schellenberger E, Kivelitz D, Krug L, Dewey M, Laule M, Hamm B, Taupitz M.
Coronary MR angiography using citrate-coated very small superparamagnetic iron oxide particles as blood-pool contrast agent: initial experience in humans.
J Magn Reson Imaging. 2011 Oct;34(4):816-23.

25. Bahmani P., Schellenberger E., Klohs J., Steinbrink J., Cordell R., Zille M., Müller J., Harhausen D., Hofstra L., Reutelingsperger C., Dirnagl U., and Wunder A.
(2011) Visualization of cell death in mice with focal cerebral ischemia using fluorescent annexin A5, propidium iodide, and TUNEL staining.
J Cereb Blood Flow Metab

24. Haeckel A, Schoenzart L, Appler F, Schnorr J, Taupitz M, Hamm B., Schellenberger E,
Combined In Situ Zymography, Immunofluorescence, And Staining Of Iron Oxide Particles In Paraffin-embedded, Zinc-fixed Tissue Sections.
Mol Imaging. 2011;11(5):1-6.

23. Schellenberger E.
Bioresponsive nanosensors in medical imaging.
J R Soc Interface. 2010 Feb 6;7 Suppl 1:S83-91. Epub 2009 Oct 21.

22. Schellenberger E, Rudloff F, Warmuth C, Taupitz M, Hamm B, Schnorr J.
Protease-specific nanosensors for magnetic resonance imaging.
Bioconjug Chem. 2008 Dec;19(12):2440-5

21. Schellenberger, E., Schnorr, J., Reutelingsperger, C., Ungethum, L
et al. Linking Proteins with Anionic Nanoparticles via Protamine: Ultrasmall Protein-Coupled Probes for Magnetic Resonance Imaging of Apoptosis.
Small 4, 225-230 (2008).

20. Schellenberger, E.
in Nanoparticles in Biomedical Imaging T1 - Magnetoptical Probes
199-207 (Springer 2007).

19. Schellenberger E, Wagner S, Schnorr J.
in Production of targeted MRI probes by biocompa-tible coupling of macromolecules with charged nanoparticles.
Patent application 07015538.7-1216, 2007.

18. Schellenberger, E.
in Textbook of in vivo Imaging in Vertebrates
(eds Tavitian, B., Leroy-Willig, A. & Ntziachristos, V.) 301 (John Wiley & Sons, Ltd, 2007).

17. Morawietz, H., Rohrbach, S., Rueckschloss, U., Schellenberger, E.
et al. Increased cardiac endothelial nitric oxide synthase expression in patients taking angiotensin-converting enzyme inhibitor therapy.
Eur J Clin Invest 36, 705-712 (2006).

16. Schnorr J, Wagner S, Abramjuk C, Drees R, Schink T, Schellenberger EA, Pilgrimm H, Hamm B, Taupitz M.
et al. Focal Liver Lesions: SPIO-, Gadolinium-, and Ferucarbotran-enhanced Dynamic T1-weighted and Delayed T2-weighted MR Imaging in Rabbits.
Radiology (2006).

15. Sosnovik, D. E., Schellenberger, E. A., Nahrendorf, M., Novikov, M. S.
et al. Magnetic resonance imaging of cardiomyocyte apoptosis with a novel magneto-optical nanoparticle.
Magn Reson Med 54, 718-724 (2005).

14. Wunder, A., Schellenberger, E., Mahmood, U., Bogdanov, A.J.
et al. Methotrexate-induced accumulation of fluorescent annexin V in collagen-induced arthritis.
Mol Imaging 4, 1-6 (2005).

13. Schellenberger, E.
[Applications of optical imaging].
Z Med Phys 15, 187-191 (2005).

12. Schellenberger, E. A., Sosnovik, D., Weissleder, R. & Josephson, L.
Magneto/optical annexin V, a multimodal protein.
Bioconjug Chem 15, 1062-1067 (2004).

11. Schellenberger, E. A., Weissleder, R. & Josephson, L.
Optimal modification of annexin V with fluorescent dyes.
Chembiochem 5, 271-274 (2004).

10. Schellenberger, E. A., Reynolds, F., Weissleder, R. & Josephson, L.
Surface-functionalized nanoparticle library yields probes for apoptotic cells.
Chembiochem 5, 275-279 (2004).

9. Bogdanov, A, Schellenberger, E, Petrovsky, A and Josephson, L.
In vivo imaging of apoptosis. WO 03/105814.

8. Schnorr, J., Wagner, S., Abramjuk, C., Wojner, I.
et al. Comparison of the iron oxide-based blood-pool contrast medium VSOP-C184 with gadopentetate dimeglumine for first-pass magnetic resonance angiography of the aorta and renal arteries in pigs.
Invest Radiol 39, 546-553 (2004).

7. Ntziachristos, V., Schellenberger, E. A., Ripoll, J., Yessayan, D.
et al. Visualization of antitumor treatment by means of fluorescence molecular tomography with an annexin V-Cy5.5 conjugate.
Proc Natl Acad Sci U S A 101, 12294-12299 (2004).

6. Petrovsky, A., Schellenberger, E., Josephson, L., Weissleder, R. & Bogdanov, A. Jr.
Near-infrared fluorescent imaging of tumor apoptosis.
Cancer Res 63, 1936-1942 (2003).

5. Schellenberger, E. A., Josephson, L. & Ntziachristos, V.
Optical Imaging of Apoptosis.
Medical Laser Application 18, 191-198 (2003).

4. Schellenberger, E. A., Bogdanov, A. J., Petrovsky, A., Ntziachristos, V.
et al. Optical imaging of apoptosis as a biomarker of tumor response to chemotherapy.
Neoplasia 5, 187-192 (2003).

3. Schellenberger, E. A., Hogemann, D., Josephson, L. & Weissleder, R.
Annexin V-CLIO: a nanoparticle for detecting apoptosis by MRI.
Acad Radiol 9 Suppl 2, S310-S311 (2002).

2. Wunderbaldinger, P., Bremer, C., Schellenberger, E., Cejna, M.
et al. Imaging features of iliopsoas bursitis.
Eur Radiol 12, 409-415 (2002).

1. Schellenberger, E. A., Bogdanov, A., J., Hogemann, D., Tait, J.
et al. Annexin V-CLIO: a nanoparticle for detecting apoptosis by MRI.
Mol Imaging 1, 102-107 (2002).

Prof. Dr. med. Eyk Schellenberger

 Prof. Hamm in Australien
Professor Hamm wurde in einer Robe gesichtet. Mehr dazu...
Bewerber für einen 6-8 monatigen Forschungsaufenthalt am Yale University Hospital in New Haven, USA gesucht
Goldmedaille der AOSR an Prof. Hamm verliehen
 Graduiertenkollegs BIOQIC der DFG
Wir freuen uns über die Einrichtung des Graduiertenkollegs BIOQIC der DFG (GRK2260) an der Radiologie der Charité!
Informieren Sie sich über unser Spezialgebiet: Minimal-invasive Tumortherapie (MITT)!
 Prof. Fischer
Vorsitzender der AG Ultraschall (AGUS) der Deutschen Röntgengesellschaft
alle Nachrichten
Home   Site Map   Impressum   Kontakt   Top    Copyright © 2003-2010 Charité
entwickelt und betreut von Martin Fischer